JP2024509917A5 - - Google Patents
Info
- Publication number
- JP2024509917A5 JP2024509917A5 JP2023555231A JP2023555231A JP2024509917A5 JP 2024509917 A5 JP2024509917 A5 JP 2024509917A5 JP 2023555231 A JP2023555231 A JP 2023555231A JP 2023555231 A JP2023555231 A JP 2023555231A JP 2024509917 A5 JP2024509917 A5 JP 2024509917A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163158671P | 2021-03-09 | 2021-03-09 | |
| US63/158,671 | 2021-03-09 | ||
| PCT/US2022/019479 WO2022192346A1 (en) | 2021-03-09 | 2022-03-09 | Selective stimulation of t cells in solid tumors using oncolytic viral delivery of orthogonal il-2 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024509917A JP2024509917A (ja) | 2024-03-05 |
| JP2024509917A5 true JP2024509917A5 (https=) | 2025-03-12 |
| JPWO2022192346A5 JPWO2022192346A5 (https=) | 2025-03-12 |
Family
ID=83227027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555231A Pending JP2024509917A (ja) | 2021-03-09 | 2022-03-09 | 腫瘍溶解性ウイルスによる直交性ｉｌ－２の送達を用いた、固形腫瘍におけるｔ細胞の選択的刺激方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240299541A1 (https=) |
| EP (1) | EP4305054A4 (https=) |
| JP (1) | JP2024509917A (https=) |
| CN (1) | CN117377682A (https=) |
| WO (1) | WO2022192346A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023044457A1 (en) | 2021-09-17 | 2023-03-23 | Parker Institute For Cancer Immunotherapy | Switch receptors using il-9 signaling domains |
| US20230265147A1 (en) * | 2021-09-17 | 2023-08-24 | The Trustees Of The University Of Pennsylvania | Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune Cells |
| EP4554611A1 (en) * | 2022-07-15 | 2025-05-21 | The Regents Of The University Of California | Il-9r signaling compositions and methods |
| CN120225568A (zh) * | 2022-12-27 | 2025-06-27 | 广州瑞风生物科技有限公司 | 一种融合蛋白及其应用 |
| WO2025085721A1 (en) * | 2023-10-18 | 2025-04-24 | Memorial Sloan-Kettering Cancer Center | Chimeric receptors and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102739782B1 (ko) * | 2015-09-11 | 2024-12-09 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 생물학적으로 관련된 직교 사이토카인/수용체 쌍 |
| EP3746116A1 (en) * | 2018-01-31 | 2020-12-09 | Novartis AG | Combination therapy using a chimeric antigen receptor |
| AU2020219246A1 (en) * | 2019-02-08 | 2021-08-19 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Chimeric cytokine receptors |
| CN115996746A (zh) * | 2020-04-06 | 2023-04-21 | 辛德凯因股份有限公司 | 经基因组修饰以表达正交受体的人免疫细胞 |
-
2022
- 2022-03-09 CN CN202280033752.0A patent/CN117377682A/zh active Pending
- 2022-03-09 EP EP22767860.4A patent/EP4305054A4/en active Pending
- 2022-03-09 JP JP2023555231A patent/JP2024509917A/ja active Pending
- 2022-03-09 US US18/549,503 patent/US20240299541A1/en active Pending
- 2022-03-09 WO PCT/US2022/019479 patent/WO2022192346A1/en not_active Ceased